Press Releases

    • OCT 03 2013

    Oncoceutics and Calvert Research Announce Investment Partnership to Advance ONC201 to an IND Filing

    Hummelstown, PA (October 3, 2013) – Oncoceutics, Inc. announced the closing of an investment by Calvert Research, LLC into the company that will be used to advance ONC201 to an IND filing. Oncoceutics is developing ONC201, an orally active small molecule with a compelling efficacy and safety profile in preclinical studies against cancer cells (in

    • JUN 24 2013

    Kuwait University Medical School Professor Joins Scientific Advisory Board

    Hummelstown, PA (June 24, 2013) – Oncoceutics, Inc. announced that Kuwait University Medical School Professor Fahd Al-Mulla has joined the company’s scientific advisory board. Dr. Al-Mulla FRCP is University Professor of molecular Pathology at Kuwait University Medical School and is the director of genomic medicine at Genatak, Kuwait. Prior to joining Genatak, Dr. Al-Mulla established